Mechanism of neurofibrillary degeneration in Alzheimer's disease

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Molecular Neurobiology

• Publication date

  1994-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/BF02816111PMID 7888088
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• About the presence of paired helical filaments in dystrophic neurites participating in the plaque formation

  2004cited by this paper
• Alzheimer paired helical filaments: Bulk isolation, solubility, and protein composition

  2004cited by this paper
• Dephosphorylation of Alzheimer's disease abnormally phosphorylated tau by protein phosphatase-2A.

  1994cited by this paper
• Role of abnormally phosphorylated tau in the breakdown of microtubules in Alzheimer disease.

  1994cited by this paper
• Ubiquitin is conjugated with amino-terminally processed tau in paired helical filaments.

  1993cited by this paper
• Phosphoprotein Phosphatase Activities in Alzheimer Disease Brain

  1993cited by this paper
• Microtubule-associated protein tau. Abnormal phosphorylation of a non-paired helical filament pool in Alzheimer disease.

  1993cited by this paper
• Phosphorylation-dependent epitopes of neurofilament antibodies on tau protein and relationship with Alzheimer tau.

  1992cited by this paper
• Phosphate analysis and dephosphorylation of modified tau associated with paired helical filaments.

  1992cited by this paper
• Fetal‐Type Phosphorylation of the τ in Paired Helical Filaments

  1992cited by this paper
• Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau.

  1992cited by this paper
• MAP kinases: charting the regulatory pathways.

  1992cited by this paper
• Mitogen activated protein (MAP) kinase transforms tau protein into an Alzheimer‐like state.

  1992cited by this paper
• Heat shock induces translocation to the nucleus of the unliganded glucocorticoid receptor.

  1992cited by this paper
• Brain Levels of Microtubule‐Associated Protein τ Are Elevated in Alzheimer's Disease: A Radioimmuno‐Slot‐Blot Assay for Nanograms of the Protein

  1992cited by this paper
• The switch of tau protein to an Alzheimer‐like state includes the phosphorylation of two serine‐proline motifs upstream of the microtubule binding region.

  1992cited by this paper
• Fetal-type phosphorylation of the tau in paired helical filaments.

  1992cited by this paper
• A68: a major subunit of paired helical filaments and derivatized forms of normal Tau.

  1991cited by this paper
• Abnormal phosphorylation of tau precedes ubiquitination in neurofibrillary pathology of Alzheimer disease.

  1991cited by this paper
• Alzheimer's disease : basic mechanisms, diagnosis and therapeutic strategies

  1991cited by this paper
• Tau in Alzheimer neurofibrillary tangles. N- and C-terminal regions are differentially associated with paired helical filaments and the location of a putative abnormal phosphorylation site.

  1991cited by this paper
• The calmodulin-binding domain mediates the self-association of the plasma membrane Ca2+ pump.

  1991cited by this paper
• Ultrastructural localization of beta-amyloid, tau, and ubiquitin epitopes in extracellular neurofibrillary tangles.

  1991cited by this paper
• The microtubule-associated protein tau forms a triple-stranded left-hand helical polymer.

  1991cited by this paper
• Two novel kinases phosphorylate tau and the KSP site of heavy neurofilament subunits in high stoichiometric ratios

  1991cited by this paper
• Secondary deposition of beta amyloid within extracellular neurofibrillary tangles in Alzheimer-type dementia.

  1991cited by this paper
• [Towards the development of an in vivo study model of Alzheimer-type neurofibrillary degeneration].

  1990cited by this paper
• Expression of separate isoforms of human tau protein: correlation with the tau pattern in brain and effects on tubulin polymerization.

  1990cited by this paper
• PHF ARE LESS ACCESSIBLE THAN TAU TO ALKALINE PHOSPHATASE: 27

  1990cited by this paper
• Accumulation of abnormally phosphorylated tau precedes the formation of neurofibrillary tangles in Alzheimer's disease.

  1989cited by this paper
• Identification and localization of a tau peptide to paired helical filaments of Alzheimer disease.

  1989cited by this paper
• Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques

  1988cited by this paper
• Alzheimer's disease. A double-labeling immunohistochemical study of senile plaques.

  1988cited by this paper
• Microtubule-associated polypeptides tau are altered in Alzheimer paired helical filaments.

  1988cited by this paper
• The primary structure and heterogeneity of tau protein from mouse brain.

  1988cited by this paper
• Alzheimer's disease, microtubule and neurofilament proteins, and axoplasmic flow.

  1987cited by this paper
• Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology.

  1986cited by this paper
• Defective brain microtubule assembly in Alzheimer's disease.

  1986cited by this paper
• Tau protein function in living cells

  1986cited by this paper
• Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.

  1986cited by this paper
• Phosphorylation affects the ability of tau protein to promote microtubule assembly.

  1984cited by this paper
• A protein factor essential for microtubule assembly.

  1975cited by this paper
• Urinary hydroxyproline and protein nutrition.

  1969cited by this paper
• STAPHYLOCOCCI RESISTANT TO NEOMYCIN AND BACITRACIN.

  1965cited by this paper

• Visualization Analysis of Tau Protein in the Brain of Alzheimer's Disease: A Scoping Literature Review.

  2025cites this paper
• Influence of the Gut Microbiota on the Development of Neurodegenerative Diseases

  2022cites this paper
• Reproductive status impact on tau phosphorylation induced by chronic stress

  2020cites this paper
• Recent Expansions on Cellular Models to Uncover the Scientific Barriers Towards Drug Development for Alzheimer’s Disease

  2019cites this paper
• Epigenetic and Neurological Impairments Associated with Early Life Exposure to Persistent Organic Pollutants

  2019cites this paper
• The elusive tau molecular structures: can we translate the recent breakthroughs into new targets for intervention?

  2019cites this paper
• The Roles of Apolipoprotein E, Lipids, and Glucose in the Pathogenesis of Alzheimer's Disease.

  2019cites this paper
• Inhibition of the Nrf2/HO-1 Axis Suppresses the Mitochondria-Related Protection Promoted by Gastrodin in Human Neuroblastoma Cells Exposed to Paraquat

  2018cites this paper
• Dietary arachidonic acid: a Janus face actor in brain and Alzheimer’s disease?

  2018cites this paper
• Reduction of amyloid beta by Aβ3-10-KLH vaccine also decreases tau pathology in 3×Tg-AD mice.

  2018cites this paper
• BAG2 expression dictates a functional intracellular switch between the p38-dependent effects of nicotine on tau phosphorylation levels via the α7 nicotinic receptor.

  2016cites this paper
• Dietary arachidonic acid as a risk factor for age-associated neurodegenerative diseases: Potential mechanisms.

  2016cites this paper
• The roles of lipid and glucose metabolism in modulation of β-amyloid, tau, and neurodegeneration in the pathogenesis of Alzheimer disease

  2015influential citation
• SPECT-perfusión cerebral regional «off-on»: a propósito de un caso de catatonia

  2014cites this paper
• Deregulation of brain insulin signaling in Alzheimer’s disease

  2014cites this paper
• Cortical odor processing in health and disease.

  2014cites this paper
• Brain Alterations and Clinical Symptoms of Dementia in Diabetes: Aβ/Tau-Dependent and Independent Mechanisms

  2014cites this paper
• Diabetes and neurodegeneration in the brain.

  2014cites this paper
• Amyloid-β may be released from non-junctional varicosities of axons generated from abnormal tau-containing brainstem nuclei in sporadic Alzheimer’s disease: a hypothesis

  2013cites this paper
• Roles of vascular and metabolic components in cognitive dysfunction of Alzheimer disease: short- and long-term modification by non-genetic risk factors

  2013cites this paper
• Aβ Deposition, Insulin Signaling, and Tau Phosphorylation in Animal Models of Alzheimer Disease and Diabetes

  2013cites this paper
• Microtubule Formation and Activities of Antioxidative Enzymes in PC12 Cells Exposed to Phosphatidylcholine Hydroperoxides

  2012cites this paper
• Chronic noise exposure causes persistence of tau hyperphosphorylation and formation of NFT tau in the rat hippocampus and prefrontal cortex.

  2012cites this paper
• The role of ApoE and homocysteine in the pathogenesis of Alzheimer’s disease

  2012cites this paper
• Rational Optimization of Small Molecules for Alzheimer’s Disease Premortem Diagnosis

  2012cites this paper
• Roles of Microtubules in Maintenance of Nerve Cell Networks

  2011cites this paper
• Deregulation of Cytoskeletal Protein Phosphorylation and Neurodegeneration

  2011cites this paper
• Single‐ and Multiple‐Dose Pharmacokinetics, Safety, and Tolerability of the Selective α7 Neuronal Nicotinic Receptor Agonist, ABT‐107, in Healthy Human Volunteers

  2011cites this paper
• Mechanisms of Neural and Behavioral Dysfunction in Alzheimer’s Disease

  2011cites this paper
• Therapeutic targets in Alzheimer's disease and related tauopathies.

  2011cites this paper
• Tau Dephosphorylation Potentiates Apoptosis by Mechanisms Involving a Failed Dephosphorylation/Activation of Bcl-2

  2010cites this paper
• Drug Development for Alzheimer's Disease: Recent Progress

  2010cites this paper
• The usefulness and challenges of transgenic mouse models in the study of Alzheimer's disease.

  2010cites this paper
• Conformational changes and cleavage; are these responsible for the tau aggregation in Alzheimer’s disease?

  2009cites this paper
• Amyloid Reduction by Amyloid-β Vaccination Also Reduces Mouse Tau Pathology and Protects from Neuron Loss in Two Mouse Models of Alzheimer's Disease

  2009cites this paper
• Progression of Amyloid Pathology to Alzheimer's Disease Pathology in an Amyloid Precursor Protein Transgenic Mouse Model by Removal of Nitric Oxide Synthase 2

  2008cites this paper
• Corticotropin-Releasing Factor Receptors Differentially Regulate Stress-Induced Tau Phosphorylation

  2007cites this paper
• Troglitazone, a peroxisome proliferator‐activated receptor‐γ agonist, decreases tau phosphorylation in CHOtau4R cells

  2006cites this paper
• Biconditional discrimination learning in rats with 192 IgG-saporin lesions of the nucleus basalis magnocellularis

  2006cites this paper
• The role of insulin receptor signaling in the brain.

  2005cites this paper
• Pattern of brain destruction in Parkinson's and Alzheimer's diseases

  2005cites this paper
• The role of NMDA receptors in the slow neuronal degeneration of Parkinson's disease

  2005cites this paper
• The last neuronal division: a unifying hypothesis for the pathogenesis of Alzheimer's disease

  2005cites this paper
• Role of LRP in TGFβ2‐mediated neuronal uptake of Aβ and effects on memory

  2004cites this paper
• Structural insight into nucleotide recognition in tau-protein kinase I/glycogen synthase kinase 3 beta.

  2004cites this paper
• First evidence for helical transitions in supercoiled DNA by amyloid β peptide (1–42) and aluminum

  2004cites this paper
• First evidence for helical transitions in supercoiled DNA by amyloid Beta Peptide (1-42) and aluminum: a new insight in understanding Alzheimer's disease.

  2004cites this paper
• Differential subcellular localization of phosphorylated neurofilament and tau proteins in degenerating neurons of the human entorhinal cortex

  2003cites this paper
• Pathological Changes in the Parahippocampal Region in Select Non‐Alzheimer's Dementias

  2000cites this paper
• Neuropathology of Alzheimer’s disease: what is new since A. Alzheimer?

  1999cites this paper
• Reduced high-affinity agonist binding at the M(1) muscarinic receptor in Alzheimer's disease brain: differential sensitivity to agonists and divalent cations.

  1999cites this paper
• Dynamic Regulation of Expression and Phosphorylation of Tau by Fibroblast Growth Factor-2 In Neural Progenitor Cells from Adult Rat Hippocampus

  1999cites this paper
• Age-related hippocampal changes in Bcl-2:Bax ratio, oxidative stress, redox-active iron and apoptosis associated with aluminum-induced neurodegeneration: increased susceptibility with aging.

  1999cites this paper
• Evolution of Alzheimer's disease related cortical lesions.

  1998cites this paper
• Involvement of precerebellar nuclei in Pick's disease.

  1998cites this paper
• Pharmacological Drug Treatment of Alzheimer Disease: The Cholinergic Hypothesis Revisited

  1998cites this paper
• Evolution of neuronal changes in the course of Alzheimer's disease.

  1998cites this paper
• Neuropathological hallmarks of Alzheimer's and Parkinson's diseases.

  1998cites this paper
• Characterization of protein phosphatases in mouse oocytes.

  1998cites this paper
• Sequence-specific interactions of minor groove binders with the 154 base pair HindIII-RsaI restriction fragment of cDNA of the human Tau 40 protein involved in pathology of Alzheimer's disease.

  1997cites this paper
• The Loss of GluR2(3) Immunoreactivity Precedes Neurofibrillary Tangle Formation in the Entorhinal Cortex and Hippocampus of Alzheimer Brains

  1997cites this paper
• Low initial tau phosphorylation in human brain biopsy samples.

  1997cites this paper
• Involvement of neuronal anion exchange proteins in cell death in Alzheimer's disease.

  1997cites this paper
• Effect of Alzheimer's Brain Extracts on Dynein Immunoreactivity in PC12 Cells

  1997cites this paper
• Two‐Dimensional Characterization of Paired Helical Filament‐Tau from Alzheimer's Disease: Demonstration of an Additional 74‐kDa Component and Age‐Related Biochemical Modifications

  1997cites this paper
• Structural alterations and changes in cytoskeletal proteins and proteoglycans after focal cortical ischemia.

  1997cites this paper
• Inhibition of protein phosphatase-2B (calcineurin) activity towards Alzheimer abnormally phosphorylated tau by neuroleptics.

  1996cites this paper
• Age, neurofibrillary changes, A beta-amyloid and the onset of Alzheimer's disease.

  1996cites this paper
• The possible place of cathepsins and cystatins in the puzzle of Alzheimer disease: a review.

  1996cites this paper
• Phosphorylation of τ In Situ: Inhibition of Calcium‐Dependent Proteolysis

  1995cites this paper
• Transforming growth factor-beta: neuronal and glial expression in CNS degenerative diseases.

  1995cites this paper
• Expression of protein phosphatases (PP-1, PP-2A, PP-2B and PTP-1B) and protein kinases (MAP kinase and P34cdc2) in the hippocampus of patients with Alzheimer disease and normal aged individuals.

  1994cites this paper